Summary:
- This article discusses the development of a new cancer treatment called CAR T-cell therapy, which uses the patient's own immune cells to fight cancer.
- The article highlights the work of Dr. Bryon Johnson, a University of Wisconsin-Madison professor, who has been instrumental in advancing this innovative therapy.
- It describes how Dr. Johnson's research team has been able to take the concept of CAR T-cell therapy from the laboratory to a successful startup company, Odylia Therapeutics, which is now working to bring this treatment to patients.